Vaccinations with the BioNTech-Fosun shot will resume on Monday, an official spearheading the city's inoculation program said.
The Secretary for the Civil Service Patrick Nip Tak-kuen, said that the supplier reported the investigation results to the Department of Health today. It has reported that there are no quality and safety issues.
A new batch of about 300,000 doses of vaccine
is expected to be delivered to Hong Kong tomorrow.
On the morning of March 24, packaging defects in 57 injection vials led to the suspension of Fosun-made vaccines
Shanghai Fosun Pharma had been granted the right by Germany's BioNTech
to manufacture and market the mRNA vaccine
in mainland China, Hong Kong, Macau and Taiwan.
Elsewhere the vaccine
is marketed by Pfizer